CNTX - CIK 0001842952
Context Therapeutics Inc. trades as CNTX. This page tracks Context Therapeutics Inc. through 290 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-14 |
| SCHEDULE 13G/A | - | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-08 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-01 |
The largest companies sharing Context Therapeutics Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year Context Therapeutics Inc. reported a net loss of $36.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.